BackKaleido Biosciences Overview

Kaleido Biosciences Total Current Liabilities

Track Kaleido Biosciences's total current liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$0.00

Peer average

Loading

Kaleido Biosciences Total Current Liabilities History

Loading

Kaleido Biosciences vs. peers: Total Current Liabilities Comparison

Loading

Kaleido Biosciences Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kaleido Biosciences (KLDO) FAQ

Kaleido Biosciences (KLDO) currently reports a total current liabilities of $0 as of September 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Kaleido Biosciences's total current liabilities history and peer comparisons.

Kaleido Biosciences's total current liabilities changed from $0 to $0 (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kaleido Biosciences reported $0 in total current liabilities as of September 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kaleido Biosciences, and consider following KLDO for alerts when major investors trade the stock.

Kaleido Biosciences is classified in the Healthcare sector. On total current liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KLDO with unrelated industries.